OMEGA FUND V, L.P. purchased 82.6% of their position (481K shares) of TREVI THERAPEUTICS, INC. on the open market
Open‑market purchase worth $4.81M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/13/2019ACC: 0000899243-19-013261
10% Owner
Since May 2019
-4.07M
Net shares
Net seller
$4.81M
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
1.06M acquired · 5.14M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+582.41K
Price / share
—
Trade value
—
% of position
New position
5/9/2019
0.00→582.41K
Common Stock
Direct
Shares
+481K
Price / share
$10.00
Trade value
$4.81M
% of position
82.6%
5/9/2019
582.41K→1.06M
Total
Net shares
+1.06M
Net value
$4.81M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/9/2019 | C · Conversion | +582.41K | — | — | New position | 0.00 | 582.41K |
| Common Stock Direct | 5/9/2019 | P · Purchase | +481K | $10.00 | $4.81M | 82.6% | 582.41K | 1.06M |
| Total | +1.06M | $4.81M | ||||||
Derivative Transactions1
Series C Preferred Stock
Direct
Converts to
Common Stock
582.41K shares
Shares
−5.14M
Strike price
Held after
0.00
Exercisable
—
5/9/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C Preferred Stock Direct | Common Stock582.41K shares | 5/9/2019 | C · Conversion | −5.14M | — | 0.00 |